Bioamber (BIOA) Tops Q4 EPS by 19c

Bioamber (NYSE: BIOA) reported Q4 EPS of ($0.20), $0.19 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $308 thousand versus the consensus estimate of $400 thousand.

For earnings history and earnings-related data on Bioamber (BIOA) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty
• Benchmark Reiterates Buy Rating on Kura Sushi USA Inc. (KRUS) Ahead of Q3 Print